IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MORGANTI, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.232
AS - Asia 2.379
NA - Nord America 2.356
SA - Sud America 239
AF - Africa 90
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.317
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.239
DE - Germania 1.460
CN - Cina 741
SG - Singapore 634
IT - Italia 580
GB - Regno Unito 246
HK - Hong Kong 222
SE - Svezia 207
VN - Vietnam 177
BR - Brasile 165
IN - India 155
RU - Federazione Russa 150
BD - Bangladesh 126
FR - Francia 120
NL - Olanda 94
IE - Irlanda 88
CA - Canada 59
ES - Italia 59
FI - Finlandia 59
JP - Giappone 55
TR - Turchia 52
ID - Indonesia 50
MX - Messico 38
KR - Corea 31
CI - Costa d'Avorio 28
PL - Polonia 28
AT - Austria 24
AR - Argentina 22
EG - Egitto 22
CH - Svizzera 16
AU - Australia 15
PK - Pakistan 15
PH - Filippine 14
ZA - Sudafrica 14
BE - Belgio 13
CO - Colombia 13
JO - Giordania 11
EC - Ecuador 10
GR - Grecia 10
PE - Perù 10
RO - Romania 10
UA - Ucraina 10
LB - Libano 9
MY - Malesia 9
SA - Arabia Saudita 9
TW - Taiwan 9
CL - Cile 8
IQ - Iraq 8
VE - Venezuela 8
DK - Danimarca 7
IR - Iran 7
NO - Norvegia 7
PT - Portogallo 7
UZ - Uzbekistan 7
CZ - Repubblica Ceca 6
IL - Israele 6
KE - Kenya 6
TN - Tunisia 6
AM - Armenia 5
BG - Bulgaria 5
LT - Lituania 5
TH - Thailandia 5
CR - Costa Rica 4
MA - Marocco 4
NZ - Nuova Zelanda 4
BH - Bahrain 3
BY - Bielorussia 3
HU - Ungheria 3
JM - Giamaica 3
KG - Kirghizistan 3
NP - Nepal 3
PA - Panama 3
PS - Palestinian Territory 3
SD - Sudan 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NG - Nigeria 2
SC - Seychelles 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
AP - ???statistics.table.value.countryCode.AP??? 1
AZ - Azerbaigian 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GI - Gibilterra 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MO - Macao, regione amministrativa speciale della Cina 1
Totale 8.312
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 1.322
Dallas 358
Ashburn 337
Singapore 315
Hong Kong 194
Southend 167
Milan 161
San Jose 154
Chandler 149
Beijing 108
Council Bluffs 86
Dublin 84
Santa Clara 83
New York 82
Hefei 75
Los Angeles 67
Ho Chi Minh City 50
Hanoi 47
Princeton 44
Boardman 43
Shanghai 43
Helsinki 41
Buffalo 38
Munich 38
Istanbul 37
Bengaluru 36
Fairfield 36
Lauterbourg 35
Moscow 31
Rome 31
Abidjan 28
Jakarta 27
Guangzhou 26
Ann Arbor 23
Cambridge 22
Toronto 21
Hyderabad 20
São Paulo 20
Cangzhou 19
Houston 19
Chennai 18
Seoul 18
Berlin 17
Tokyo 17
Vienna 17
Wilmington 17
Bologna 15
Des Moines 15
Grafing 13
Naples 13
Nuremberg 13
The Dalles 13
Barcelona 12
Chicago 12
Curitiba 12
London 12
Seattle 12
Amman 11
Cairo 11
Florence 11
Madrid 11
Phoenix 11
San Diego 11
Wuhan 11
Boston 10
Brussels 10
Buenos Aires 10
Fuzhou 10
Hangzhou 10
Nanjing 10
Turin 10
Lappeenranta 9
Turku 9
Warsaw 9
Atlanta 8
Columbus 8
Düsseldorf 8
Gdansk 8
Mexico City 8
Montreal 8
Paris 8
Redwood City 8
Stockholm 8
Tianjin 8
Washington 8
Amsterdam 7
Bari 7
Brooklyn 7
Cape Town 7
Da Nang 7
Genoa 7
San Francisco 7
Shenzhen 7
Taipei 7
Ankara 6
Bucharest 6
Denver 6
Fremont 6
Jinan 6
Kuala Lumpur 6
Totale 5.124
Salva come PNG Salva come JPEG
Nome #
Biologic therapy for advanced breast cancer : recent advances and future directions 565
Margetuximab for the treatment of HER2-positive metastatic breast cancer 534
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 349
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 327
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 293
Antibody–drug conjugates in solid tumors: a look into novel targets 291
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 263
Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists 251
Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis 245
Systemic Treatment of Ductal Carcinoma In Situ of the Breast 241
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards : data from the RePoSI Registry 233
Master protocols in immuno-oncology : Do novel drugs deserve novel designs? 215
Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management 215
Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials 214
Seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2 204
Pretreatment Blood Parameters Predict Efficacy from Immunotherapy Agents in Early Phase Clinical Trials 203
Tumor-infiltrating lymphocytes (TILs) in paired samples from patients with phenotypic switch from early luminal-like to metastatic triple-negative breast cancer 202
Safety of covid-19 mrna vaccines in patients with cancer enrolled in early-phase clinical trials 200
Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life 194
What therapies are on the horizon for HER2 positive breast cancer? 193
Clinical features affecting survival in metastatic NSCLC treated with immunotherapy : A critical review of published data 181
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards : data from the RePoSI Registry 179
Clinical outcomes of patients with metastatic breast cancer enrolled in phase I clinical trials 179
I diritti dei morenti in diversi setting di cura al tempo del Covid-19. Uno studio retrospettivo trasversale sulle opinioni degli operatori sanitari. 177
HER2-Low Breast Cancer: Pathological and Clinical Landscape 176
Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions 171
Refining risk stratification in HR-positive/HER2-negative early breast cancer: how to select patients for treatment escalation? 163
Combinations using checkpoint blockade to overcome resistance 161
Clinical development and current role of margetuximab for the treatment of breast cancer 160
Characterization of low HER2 expressions in de-novo metastatic breast cancer 159
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: analysis of the REPOSI registry 149
COVID-19 related risk in patients enrolled in early-phase clinical trials 145
Baseline tumor size as prognostic index in patients with cancer receiving experimental targeted agents 145
Management of Patients with Cardiac Toxicity: The Point of View of the Oncologist 141
Optimizing treatment strategy in early breast cancer: less is more, or more is better? 129
Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study 123
Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021 122
How I treat HER2-positive early breast cancer: how long adjuvant trastuzumab is needed? 101
Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls 96
PARP Inhibitors for Breast Cancer Treatment 86
Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials 63
EGFR-TKI plus anti-angiogenic drugs in EGFR-mutated non–small cell lung cancer: A meta-analysis of randomized clinical trials 62
null 9
Artificial intelligence entering the pathology arena in oncology: current applications and future perspectives 8
null 6
null 3
Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant therapy for breast cancer 1
Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer 1
Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast Cancer 1
Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies 1
Opportunities and challenges of implementing Pharmacogenomics in cancer drug development 1
Targeting HER2 in breast cancer: new drugs and paradigms on the horizon 1
Next generation sequencing (NGS): A revolutionary technology in pharmacogenomics and personalized medicine in cancer 1
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer 1
Corrigendum to: "Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis" [Eur J Cancer 145 (2021) 197-209] 1
Totale 8.535
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.853
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.853
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 0 0 0 0 0 0 0 0 43
2021/2022626 51 49 24 33 62 60 26 56 95 42 51 77
2022/2023798 80 79 79 65 80 113 29 39 109 34 62 29
2023/20241.485 33 44 41 69 141 85 206 174 98 174 213 207
2024/20251.973 182 226 162 200 123 75 53 162 101 182 191 316
2025/20263.262 355 487 354 258 243 149 390 109 278 209 336 94
Totale 8.535